← Open Payments lookup

SUNAMITA DA SILVA: Open Payments

NPI 1770069833 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$929 in 42 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $61 · 2025 $929

Food & beverage: $929
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.6$129
ABBVIE INC.7$125
PFIZER INC.5$116
GENZYME CORPORATION4$101
Janssen Biotech, Inc.4$78
Daiichi Sankyo Inc.3$74
QOL Medical, LLC3$69
Ardelyx, Inc.2$56
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$41
Lilly USA, LLC2$39

Products named: DUPIXENT, ENTYVIO, TREMFYA, XELJANZ, INJECTAFER, Sucraid, IBSRELA, RINVOQ.

Industry payments across MD — which companies pay providers there.